Back

Fostering innovation: advancing research and development of next-generation anti-arrhythmic drugs

14 April 2026 (13:45 - 14:00)
Organised by: Logo
Congress Presentation Part of: Critical medicines, critical times: addressing drug availability for arrhythmia patients topic type Antiarrhythmic Drug Treatment EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Associate Professor Carol Ann Remme

Amsterdam University Medical Centre (AUMC), Amsterdam (Netherlands (The))

3 More presentations in this session

Presentation thumbnail
The European Medicines Agency's list of critical medicines: policies and impact on cardiovascular drug availability
Ms M. Ronconi (BE)
Video
Presentation thumbnail
Mapping the crisis: insights from the EHRA survey on anti-arrhythmic drug availability
Doctor P. Postema (Amsterdam, NL)
Video
Presentation thumbnail
Ensuring access to critical drugs: harnessing policy, technology, and advocacy
Professor L. Szumowski (Warsaw, PL)
Slides Video

Access the full session

Session thumbnail
Critical medicines, critical times: addressing drug availability for arrhythmia patients topic type
Video

The Event

Event poster

EHRA 2026

14 April 2026 13:45 CET
You may be interested in
thumbnail
Congress Presentation
Promising electrical targets for novel antiarrhythmic strategies in atrial fibrillation
thumbnail
Congress Presentation
New targeted antiarrhythmic drugs
thumbnail
Congress Presentation
New AADs: what's in the pipeline?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources